IMULAN's
products
give animal
owners better
solutions for
their pet’s
diseases.
IMULAN BioTherapeutics, LLC is a privately held bioscience company pioneering the development of precision immunomodulators for veterinary medicine. We are dedicated to delivering innovative immune based treatments for a variety of challenging and life threatening animal diseases. Our first commercial product, Lymphocyte T-Cell Immunomodulator (LTCI), is the first and only approved treatment aid in the United States for FeLV and FIV.
Using our technology platforms, IMULAN is rapidly developing new, first-in-class biologics. IMULAN’s technologies target fundamental aspects of disease by modulating cells that coordinate the immune response and inflammation. IMULAN has global animal health rights to the following technology platforms.
IN MARKET
Lymphocyte T-Cell Immunomodulator (LTCI) is a polypeptide that regulates lymphocyte and cytokine production. LTCI has been conditionally approved for FeLV and FIV infections.
Lymphocyte T-Cell Immunomodulator has received a conditional license from the United States Department of Agriculture. Additional efficacy and potency studies are in progress.
DOWNLOAD: LTCI Product Brochure
ImSAIDs™ is a trademark of IMULAN BioTherapeutics, LLC
IN DEVELOPMENT
Immune Selective Anti-Inflammatory Derivatives (ImSAIDs™) are peptides that modulate the innate immune response to reduce inflammation without the side effects of steroids and non-steroidal anti-inflammatory drugs.
ImSAIDs™ Diseases of Interest:
• Inflammatory bowel disease
• Feline asthma
• Osteoarthritis
• Spinal trauma
• Sepsis
TCR Peptide Vaccines modulate
T-helper cell activity and have demonstrated the ability to restore cell mediated immunity, normalize Th1/Th2 balance, and reduce morbidity associated with infections and cardiomyopathy.
TCR Peptide Vaccines Diseases of Interest:
• Feline immune mediated inflammation
• Atopic dermatitis and pyoderma
• Dilated cardiomyopathy
• Autoimmune disorders
• Stomatitis
• Uveitis
DOWNLOAD: ImSAIDs™ Technology Summary
DOWNLOAD: TCR Peptide Summary
